- Home
- RPTX
as 11-17-2025 3:46pm EST
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
| Founded: | 2016 | Country: | Canada |
| Employees: | N/A | City: | SAINT-LAURENT |
| Market Cap: | 78.2M | IPO Year: | 2020 |
| Target Price: | $3.50 | AVG Volume (30 days): | 670.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.89 - $4.07 | Next Earning Date: | 11-14-2025 |
| Revenue: | $11,870,000 | Revenue Growth: | -82.16% |
| Revenue Growth (this year): | -80.45% | Revenue Growth (next year): | -2.44% |
Latest Repare Therapeutics Inc. News
RPTX Breaking Stock News: Dive into RPTX Ticker-Specific Updates for Smart Investing
Zacks
3 days ago
Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3
MT Newswires
3 days ago
Repare Therapeutics Agrees to Be Acquired by XenoTherapeutics; Shares Halted
Business Wire
3 days ago
Repare Therapeutics Enters into Definitive Agreement to be Acquired by XenoTherapeutics, Inc.
Simply Wall St.
18 days ago
Here's Why Repare Therapeutics (NASDAQ:RPTX) Must Use Its Cash Wisely
GlobeNewswire
a month ago
Prelude Therapeutics Announces Appointment of Katina Dorton, J.D., MBA to its Board of Directors
Business Wire
a month ago
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Business Wire
6 months ago
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
Pharmaceutical Technology
7 months ago
Repare signs out-licensing deal with DCx Biotherapeutics
Compare RPTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RPTX Repare Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.